Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Salarius Pharmaceuticals, Inc. (SLRX) had Return on Equity of 115.44% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.96M |
|
-- |
|
-- |
|
$0.97M |
|
$-0.97M |
|
$0.01M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.96M |
|
$-0.97M |
|
$-0.96M |
|
2.12M |
|
2.12M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$1.36M |
|
-- |
|
$0.03M |
|
$1.39M |
|
$2.22M |
|
-- |
|
-- |
|
$2.22M |
|
$-0.83M |
|
$-0.83M |
|
$-0.83M |
|
2.13M |
|
| Cash Flow Statement Financials | |
$-2.04M |
|
-- |
|
$0.40M |
|
$2.43M |
|
$0.79M |
|
$-1.64M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
115.44% |
115.44% |
|
-68.77% |
|
115.44% |
|
$-0.39 |
|
$-0.96 |
|
$-0.96 |
|